Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
SRI International has spun off Bridge Pharmaceuticals, a drug development services group that works with laboratories in Asia to serve the U.S. and European markets. Bridge raised $3.5 million in an investment round led by WI Harper Group. The company will continue to work in partnership with SRI's PharmaStart initiative, a consortium including four California universities aimed at expediting the development of university-based drug research. Bridge has licensed from SRI three late-stage preclinical drugs for cancer treatment.
This article has been sent to the following recipient: